Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base

Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base

(2016) Alina M. Mateo et al.   JOURNAL OF SURGICAL ONCOLOGY

Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma

(2014) Inhye Park et al.   Journal of Breast Cancer

Clinicopathologic Characteristics of Typical Medullary Breast Carcinoma: A Retrospective Study of 117 Cases

(2014) Zhaohui Chu et al.   PLoS One

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials

(2012) J. Huober et al.   ANNALS OF ONCOLOGY

Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

(2010) Marco Colleoni et al.   JOURNAL OF CLINICAL ONCOLOGY

Medullary carcinoma of the breast: a population-based perspective

(2010) Steve R. Martinez et al.   MEDICAL ONCOLOGY

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

(2008) Karl Y. Bilimoria et al.   ANNALS OF SURGICAL ONCOLOGY